Institutional Ownership
Keros Therapeutics Inc
CUSIP 492327101COMKROSQ1 2026
Institutional Holders
146
13F filers
Shares Held
16.94M
Aggregate institutional
Institutional Value
$183.28M
Q1 2026
Net New Holders
-14
23 new · 37 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions23
Increased47
Decreased54
Sold out37
Institutional Holders
146 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 2.41M | $26.63M | +121.3K | Added |
| 2 | Nantahala Capital Management, LLC | 1.36M | $15.02M | +1.00M | Added |
| 3 | Orbimed Advisors LLC | 759.2K | $8.38M | −45.1K | Reduced |
| 4 | Qube Research & Technologies Ltd | 724.9K | $8.00M | −59.0K | Reduced |
| 5 | Jacobs Levy Equity Management, Inc | 706.1K | $7.80M | −62.4K | Reduced |
| 6 | Federated Hermes, Inc. | 689.2K | $7.61M | +34.5K | Added |
| 7 | Geode Capital Management, LLC | 681.5K | $7.52M | +46.3K | Added |
| 8 | Madison Avenue Partners, LP | 626.6K | $6.92M | −197.1K | Reduced |
| 9 | Arrowstreet Capital, Limited Partnership | 590.2K | $6.52M | −744.3K | Reduced |
| 10 | State Street Corp | 561.7K | $6.20M | −514.3K | Reduced |
136 more institutional holders on Premium
See every fund holding Keros Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders